Skip to main content

Peer Review reports

From: BCG+MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301)

Original Submission
28 Feb 2015 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
13 May 2015 Editorially accepted
27 May 2015 Article published 10.1186/s12885-015-1431-6

You can find further information about peer review here.

Back to article page